_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Product deliveries scheduled in Q3 of 2023
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Subscribe To Our Newsletter & Stay Updated
